Literature DB >> 30510311

Occult tonsillar squamous cell carcinoma in 2 dogs presenting for treatment of primary oral squamous cell carcinoma.

Nicholas J Rancilio1, Christopher M Fulkerson1.   

Abstract

Canine non-tonsillar oral squamous cell carcinoma (OSCC) is generally regarded as locally invasive with low rates of metastasis. Two cases of canine non-tonsillar OSCC with occult tonsillar squamous cell carcinoma (TSCC) detected with tonsillar biopsies are reported. Tonsillar biopsies and detection of occult TSCC changed the therapeutic plan and may have contributed to long-term tumor control.

Entities:  

Mesh：

Year:  2018        PMID： 30510311      PMCID： PMC6135270     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  16 in total

Review 1.  Radiation therapy of canine nontonsillar squamous cell carcinoma.

Authors:  Candace K Grier; Monique N Mayer
Journal:  Can Vet J       Date:  2007-11       Impact factor: 1.008

2.  Veterinary cooperative oncology group - common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1.

Authors: 
Journal:  Vet Comp Oncol       Date:  2016-12       Impact factor: 2.613

3.  Canine tonsillar squamous cell carcinoma -- a multi-centre retrospective review of 44 clinical cases.

Authors:  A Mas; L Blackwood; P Cripps; S Murphy; J De Vos; N Dervisis; M Martano; G A Polton
Journal:  J Small Anim Pract       Date:  2011-07       Impact factor: 1.522

4.  Outcome following curative-intent surgery for oral melanoma in dogs: 70 cases (1998-2011).

Authors:  Joanne L Tuohy; Laura E Selmic; Deanna R Worley; Nicole P Ehrhart; Stephen J Withrow
Journal:  J Am Vet Med Assoc       Date:  2014-12-01       Impact factor: 1.936

5.  Role of carboplatin in multi-modality treatment of canine tonsillar squamous cell carcinoma--a case series of five dogs.

Authors:  S Murphy; A Hayes; V Adams; G Maglennon; P Neath; J Ladlow; M J Brearley
Journal:  J Small Anim Pract       Date:  2006-04       Impact factor: 1.522

6.  Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs.

Authors:  B R Schmidt; N W Glickman; D B DeNicola; A E de Gortari; D W Knapp
Journal:  J Am Vet Med Assoc       Date:  2001-06-01       Impact factor: 1.936

7.  Outcome and prognostic factors following curative-intent surgery for oral tumours in dogs: 234 cases (2004 to 2014).

Authors:  B N Sarowitz; G J Davis; S Kim
Journal:  J Small Anim Pract       Date:  2017-02-22       Impact factor: 1.522

8.  Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs.

Authors:  Pedro A Boria; Daryl J Murry; Peter F Bennett; Nita W Glickman; Paul W Snyder; Brenna L Merkel; Deborah L Schlittler; Anthony J Mutsaers; Rose M Thomas; Deborah W Knapp
Journal:  J Am Vet Med Assoc       Date:  2004-02-01       Impact factor: 1.936

9.  Piroxicam and carboplatin as a combination treatment of canine oral non-tonsillar squamous cell carcinoma: a pilot study and a literature review of a canine model of human head and neck squamous cell carcinoma.

Authors:  J P de Vos; A G D Burm; A P Focker; H Boschloo; M Karsijns; I van der Waal
Journal:  Vet Comp Oncol       Date:  2005-03       Impact factor: 2.613

10.  Risk factors associated with survival in dogs with nontonsillar oral squamous cell carcinoma 31 cases (1990-2010).

Authors:  Amy J Fulton; Ana Nemec; Brian G Murphy; Philip H Kass; Frank J M Verstraete
Journal:  J Am Vet Med Assoc       Date:  2013-09-01       Impact factor: 1.936
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.